Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

258
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
258
Positron Emission Tomography01:29

Positron Emission Tomography

6.1K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the imaging calibration factor for quantitative SPECT/CT of actinium-225.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

[<sup>18</sup>F]FDG PET/MRI in Pediatric Focal Epilepsies.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Long-term toxicity of tandem radioligand therapy using [<sup>90</sup>Y]Y/[<sup>177</sup>Lu]Lu-DOTA-TATE in neuroendocrine tumors: a polish multicenter experience with 20-year follow-up.

European journal of nuclear medicine and molecular imaging·2026
Same author

Precision pathways: optimising amyloid PET for sustainable Alzheimer's disease care.

Journal of neurology·2026
Same author

Aripiprazole‑induced akathisia associated with bilateral putaminal hypermetabolism on PET.

International clinical psychopharmacology·2026
Same author

Stem cells therapy molecular tracking - the special focus on nuclear medicine.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology·2026
Same journal

Evidence-based data on PET in infectious and inflammatory diseases.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026
Same journal

Evidence-based PET in cardiovascular infectious diseases: an umbrella review.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026
Same journal

Evidence-based role of PET imaging in cardiac and systemic sarcoidosis: an umbrella review of the current literature.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026
Same journal

Response assessment in [177Lu]PSMA: where do we stand?

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026
Same journal

FDG PET/CT imaging in recurrent papillary thyroid cancer: does BRAF mutation status matter?

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026
Same journal

Radionuclide lung scintigraphy in the evaluation of suspected acute and chronic pulmonary embolism: methods, interpretation, and lexicon. A basic user guide for the clinician.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2026
See all related articles

Related Experiment Video

Updated: Oct 10, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.9K

Challenges in theragnostics.

Laura Evangelista1, Diego Cecchin2, Jolanta Kunikowska3

  • 1Unit of Nuclear Medicine, Department of Medicine (DIMED), Padua University Hospital, Padua, Italy - laura.evangelista@unipd.it.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of
|December 9, 2021
PubMed
Summary
This summary is machine-generated.

Precision medicine, combining therapy and diagnostics (theranostics), faces challenges in implementation. This study analyzes demand, costs, infrastructure needs, and development opportunities for theranostic advancements.

More Related Videos

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

584
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Related Experiment Videos

Last Updated: Oct 10, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.9K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

584
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiopharmacology

Background:

  • Precision medicine aims to tailor treatments to individual patients.
  • Theranostics integrates diagnostics and therapeutics at the molecular level using radiopharmaceuticals.
  • Implementing theranostics in clinical practice presents significant hurdles.

Purpose of the Study:

  • To analyze key challenges in the field of theranostics.
  • To discuss factors influencing the adoption of theranostic approaches.
  • To explore opportunities for future theranostic development.

Main Methods:

  • Expert discussion and analysis of theranostic implementation challenges.
  • Focus on non-clinical aspects of theranostic integration.
  • Evaluation of economic and infrastructural factors.

Main Results:

  • The balance between demand and the high costs of theranostics is a major challenge.
  • The necessity for appropriate infrastructures is critical for theranostic deployment.
  • Opportunities for new developments exist despite current obstacles.

Conclusions:

  • Theranostics holds significant promise for precision medicine.
  • Addressing challenges related to cost, infrastructure, and demand is crucial for advancing theranostics.
  • Continued research and development are essential to overcome implementation barriers.